Clinical outcome of ≥2% circulating tumor cells in newly diagnosed multiple myeloma: insights from a multicenter study

Purpose Previous studies have shown that ≥2% circulating tumor cells (CTCs) in multiple myeloma are associated with a prognosis similar to primary plasma cell leukemia. This study aims to examine this ultra-high-risk patient subset and evaluate their clinical outcomes in a real-world clinical settin...

Full description

Bibliographic Details

Published in:	Annals of Medicine
Main Authors:	Dong Liang, Yurong Yan, Shenrui Bai, Weiling Xu, Qiaoli Wang, Demei Feng, Yuying Bu, Min Zeng, Xiaomiao Nie, Yuan Feng, Xiaoqin Chen, Zhongjun Xia, Yang Liang, Fengyan Jin, Hua Wang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Circulating tumor cells clinical outcome multiple myeloma
Online Access:	https://www.tandfonline.com/doi/10.1080/07853890.2025.2496796